Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. Diab A, Tykodi SS, Daniels GA, Maio M, et al. J Clin Oncol 2021 Jul 13:JCO2100675. doi: 10.1200/JCO.21.00675.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Diab A, Tykodi SS, Daniels GA, Maio M, et al. Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. J Clin Oncol 2021 Jul 13:JCO2100675. doi: 10.1200/JCO.21.00675.
PMID: 34255535